Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-13 to 2024-01-05
Current total value of award: $5469.92
Description: 4563164456!NEXPLANON 68 MG IMPLANTS